- Home
- PHIO vs EVGN Comparison
PHIO vs EVGN Comparison
Compare PHIO & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- EVGN
- Stock Information
- Founded
- PHIO 2011
- EVGN 1999
- Country
- PHIO United States
- EVGN Israel
- Employees
- PHIO N/A
- EVGN N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- PHIO Health Care
- EVGN Industrials
- Exchange
- PHIO Nasdaq
- EVGN Nasdaq
- Market Cap
- PHIO 12.1M
- EVGN 10.9M
- IPO Year
- PHIO N/A
- EVGN N/A
- Fundamental
- Price
- PHIO $1.27
- EVGN $1.20
- Analyst Decision
- PHIO Strong Buy
- EVGN Strong Buy
- Analyst Count
- PHIO 3
- EVGN 1
- Target Price
- PHIO $10.67
- EVGN $3.50
- AVG Volume (30 Days)
- PHIO 8.6M
- EVGN 54.1K
- Earning Date
- PHIO 11-13-2025
- EVGN 11-20-2025
- Dividend Yield
- PHIO N/A
- EVGN N/A
- EPS Growth
- PHIO N/A
- EVGN N/A
- EPS
- PHIO N/A
- EVGN N/A
- Revenue
- PHIO N/A
- EVGN $9,444,000.00
- Revenue This Year
- PHIO N/A
- EVGN N/A
- Revenue Next Year
- PHIO N/A
- EVGN $12.35
- P/E Ratio
- PHIO N/A
- EVGN N/A
- Revenue Growth
- PHIO N/A
- EVGN 42.25
- 52 Week Low
- PHIO $0.97
- EVGN $0.95
- 52 Week High
- PHIO $9.79
- EVGN $2.42
- Technical
- Relative Strength Index (RSI)
- PHIO 21.73
- EVGN 48.62
- Support Level
- PHIO $1.50
- EVGN $1.15
- Resistance Level
- PHIO $4.19
- EVGN $1.33
- Average True Range (ATR)
- PHIO 0.30
- EVGN 0.06
- MACD
- PHIO -0.05
- EVGN -0.00
- Stochastic Oscillator
- PHIO 0.34
- EVGN 47.62
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.